National Cancer Institute                                      U.S. National Institutes of Health | www.cancer.gov

  Cancer Imaging Program
Print Friendly Version | Images Version | Contact Us  
Home
About CIP
Research Funding
Programs & Resources
Clinical Trials
 
Imaging Guidelines
 
Screening and Interventional Trials
 
Radiology Network (ACRIN)
 
Imaging Response Criteria
 
Single Institution Feasibility Trials (R21)
 
Phase I/II Trials
Reports & Publications
News & Meetings
Imaging Information
Imaging Guidelines
Clinical Trials
Imaging Guidelines for Clinical Trials

Dynamic contrast MRI (DCE-MRI) - guidelines resulted from the NCI CIP MR Workshop on Translational Research in Cancer - Tumor Response, Bethesda, MD, November 22-23, 2004.

Magnetic resonance spectroscopy (MRS) - guidelines resulted from the NCI CIP MR Workshop on Translational Research in Cancer - Tumor Response, Bethesda, MD, November 22-23, 2004.

Fluorodeoxyglucose PET (FDG PET) - guidelines resulted from the NCI CIP workshop convened on January 10-11, 2005, in Washington, DC.

National Cancer InstituteDepartment of Health & Human ServicesNational Institutes of HealthFirstGov.gov